Herpesvirus
New HSV antiviral drugs developed to counteract problems of current therapies
Published in Immunotherapy Weekly, October 13th, 2004
"Herpes simplex virus (HSV) infections affect nearly 150 million Americans, of which 40-60 million are infected with HSV-2 and up to an additional 1 million new individuals are infected each year. The current treatment for HSV infections are nucleoside analogues such as acyclovir, valacyclovir and famciclovir," wrote investigators an Expert Opinion on Therapeutic Patents review.
"Despite the safety and efficacy of these agents," said S.M. Firestine and colleagues, "many of these agents possess limited oral bioavailability,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
Source: Immunotherapy Weekly (2004-10-13)
More Articles from Immunotherapy Weekly
- Allergy Medicine
Mouse models can enhance understanding of global airway allergy syndrome - Autoimmune Disease
Autoimmune mucocutaneous blistering disease treated with immunoglobulin - Immunodeficiency Disorder
Flow cytometry confirms Wiskott-Aldrich syndrome in youth with thrombocytopenia - Immunology
Milk SIgA affected by mom's immune/infection status; other factors may have role - Melanoma Vaccine
Immunotherapy for melanoma reviewed - Streptococcus Vaccine
Sialic acid O-acetylation in group B Streptococcus characterized - More from this issue of Immunotherapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
